Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-16-132566
Filing Date
2016-07-13
Accepted
2016-07-13 16:23:39
Documents
2
Period of Report
2016-07-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7505
2 POA DOCUMENT poa.txt EX-24.4_666653 3363
  Complete submission text file 0001209191-16-132566.txt   12469
Mailing Address FIRST FLOOR, BLOCK 3, THE OVAL, SHELBOURNE ROAD, BALLSBRIDGE DUBLIN L2 00000
Business Address FIRST FLOOR, BLOCK 3, THE OVAL, SHELBOURNE ROAD, BALLSBRIDGE DUBLIN L2 00000 353 1 6699 020
AMARIN CORP PLC\UK (Issuer) CIK: 0000897448 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3280 BAYSHORE BOULEVARD BRISBANE CA 94005
Business Address
Ekman Lars (Reporting) CIK: 0001376117 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-21392 | Film No.: 161765817